Literature DB >> 23903830

Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Nadezhda E Yun1, Alexey V Seregin, David H Walker, Vsevolod L Popov, Aida G Walker, Jeanon N Smith, Milagros Miller, Juan C de la Torre, Jennifer K Smith, Viktoriya Borisevich, Joseph N Fair, Nadia Wauquier, Donald S Grant, Bayon Bockarie, Dennis Bente, Slobodan Paessler.   

Abstract

Lassa fever (LF) is a potentially lethal human disease that is caused by the arenavirus Lassa virus (LASV). Annually, around 300,000 infections with up to 10,000 deaths occur in regions of Lassa fever endemicity in West Africa. Here we demonstrate that mice lacking a functional STAT1 pathway are highly susceptible to infection with LASV and develop lethal disease with pathology similar to that reported in humans.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23903830      PMCID： PMC3807383          DOI： 10.1128/JVI.01433-13

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  17 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Clinical virology of Lassa fever in hospitalized patients.

Authors:  K M Johnson; J B McCormick; P A Webb; E S Smith; L H Elliott; I J King
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

4.  Pathophysiology and treatment of Lassa fever.

Authors:  S P Fisher-Hoch; J B McCormick
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

5.  Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization.

Authors:  P B Jahrling; J D Frame; J B Rhoderick; M H Monson
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

6.  Pathologic and virologic study of fatal Lassa fever in man.

Authors:  D H Walker; J B McCormick; K M Johnson; P A Webb; G Komba-Kono; L H Elliott; J J Gardner
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

7.  Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis.

Authors:  D H Walker; H Wulff; J V Lange; F A Murphy
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

8.  Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells.

Authors:  Sylvain Baize; Jérôme Kaplon; Caroline Faure; Delphine Pannetier; Marie-Claude Georges-Courbot; Vincent Deubel
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

9.  Lassa virus hepatitis: a study of fatal Lassa fever in humans.

Authors:  J B McCormick; D H Walker; I J King; P A Webb; L H Elliott; S G Whitfield; K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

Review 10.  Pathogenesis of Lassa fever.

Authors:  Nadezhda E Yun; David H Walker
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048
View more
  31 in total

Review 1.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

2.  Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.

Authors:  Nhi Ngo; Kristina Schimmelpfeng Henthorn; Maria Isabel Cisneros; Beatrice Cubitt; Masaharu Iwasaki; Juan C de la Torre; Juan Lama
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection.

Authors:  Nadezhda E Yun; Shannon Ronca; Atsushi Tamura; Takaaki Koma; Alexey V Seregin; Kelly T Dineley; Milagros Miller; Rebecca Cook; Naoki Shimizu; Aida G Walker; Jeanon N Smith; Joseph N Fair; Nadia Wauquier; Bayon Bockarie; Sheik Humarr Khan; Tomoko Makishima; Slobodan Paessler
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.

Authors:  Junki Maruyama; Rachel A Reyna; Megumi Kishimoto-Urata; Shinji Urata; John T Manning; Nantian Harsell; Rebecca Cook; Cheng Huang; Janko Nikolich-Zugich; Tomoko Makishima; Slobodan Paessler
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

5.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

6.  In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.

Authors:  Qinfeng Huang; Junjie Shao; Shuiyun Lan; Yanqin Zhou; Junji Xing; Changjiang Dong; Yuying Liang; Hinh Ly
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

7.  Auditory function analysis in immunodeficient STAT1 knock-out mice: Considerations for viral infection models.

Authors:  Tomoharu Suzuki; Junki Maruyama; Rebecca Cook; Shinji Urata; Slobodan Paessler; Tomoko Makishima
Journal:  Neurosci Lett       Date:  2020-10-15       Impact factor: 3.046

Review 8.  Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.

Authors:  Takaaki Koma; Cheng Huang; Olga A Kolokoltsova; Allan R Brasier; Slobodan Paessler
Journal:  J Mol Biol       Date:  2013-09-26       Impact factor: 5.469

Review 9.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

10.  Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.

Authors:  Jian-Da Lin; Ningguo Feng; Adrish Sen; Murugabaskar Balan; Hsiang-Chi Tseng; Constance McElrath; Sergey V Smirnov; Jianya Peng; Linda L Yasukawa; Russell K Durbin; Joan E Durbin; Harry B Greenberg; Sergei V Kotenko
Journal:  PLoS Pathog       Date:  2016-04-29       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.